CN112641824A - Chinese medicine clinopodium polycephalum flow extraction method - Google Patents
Chinese medicine clinopodium polycephalum flow extraction method Download PDFInfo
- Publication number
- CN112641824A CN112641824A CN202011599342.1A CN202011599342A CN112641824A CN 112641824 A CN112641824 A CN 112641824A CN 202011599342 A CN202011599342 A CN 202011599342A CN 112641824 A CN112641824 A CN 112641824A
- Authority
- CN
- China
- Prior art keywords
- clinopodium polycephalum
- ethanol
- extract
- extracting
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001563035 Clinopodium polycephalum Species 0.000 title claims abstract description 86
- 238000000605 extraction Methods 0.000 title claims abstract description 43
- 239000003814 drug Substances 0.000 title claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 102
- 239000000284 extract Substances 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 17
- 239000000469 ethanolic extract Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 238000010924 continuous production Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 238000005520 cutting process Methods 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 241001113925 Buddleja Species 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 241001062954 Clinopodium Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- 241000717662 Clinopodium chinense Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- RMCRQBAILCLJGU-UHFFFAOYSA-N Neoponcirin Natural products C1=CC(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 RMCRQBAILCLJGU-UHFFFAOYSA-N 0.000 description 1
- 206010057739 Purpura non-thrombocytopenic Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- -1 beta-sterol Natural products 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000008728 purpura simplex Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a Chinese medicine clinopodium polycephalum extraction process which comprises the steps of firstly extracting with 50-85 vol.% ethanol as an extraction solvent, then decocting with water, and finally concentrating. The method can improve the content of buddlejasaponins IVb in the clinopodium polycephalum extract, has simple process and can be used for continuous production.
Description
Technical Field
The invention relates to the technical field of extraction processes of effective components of traditional Chinese medicines, in particular to a Chinese medicine clinopodium polycephalum extraction process.
Background
The Clinopodium polycephalum is dry overground part of Clinopodium chinensis (Benth) O. Kuntze and Clinopodium pdycephalum (Vaniot) C.Y. Wuet Hsuan plants in Clinopodium of Labiatae, is a common traditional Chinese medicine collected in pharmacopoeia of the people's republic of China in 2015 edition, has the effects of cooling blood and stopping bleeding, is clinically a good hemostatic medicine, and is mainly used for treating bleeding such as metrorrhagia, hematuria, epistaxis, gingival bleeding, traumatic bleeding, hysteromyoma bleeding and the like. The clinopodium polycephalum contains complex components, mainly contains buddlein IVb, melissoside, hesperidin, beta-sterol, isosakuranetin-7-rutinoside, apigenin, ursolic acid, taraxacin and the like, wherein triterpenoid saponins are main components. Modern pharmacological research and clinical tests prove that the saponin components of the medicine have the effects of treating various haemorrhages, purpura simplex, idiopathic thrombocytopenic purpura and the like, wherein buddleia saponins IVb is one of the effective components. Therefore, the buddlejasaponins IVb in the clinopodium polycephalum can be extracted to the maximum extent, and the method has important practical significance for exerting the efficacy of the extract.
The clinopodium polycephalum flow extraction process comprises a water extraction and alcohol precipitation method, an alcohol extraction method, an enzyme extraction method and the like, wherein the water extraction and alcohol precipitation method and the alcohol extraction method are commonly used, but the extraction rate of buddleia saponins IVb is not very high. The process for extracting the Chinese medicinal clinopodium polycephalum flow aims at improving the content of buddleja saponins IVb to the maximum extent so as to provide a certain theoretical basis and process reference for further development and utilization of the clinopodium polycephalum flow.
Disclosure of Invention
The invention aims to provide a Chinese medicine clinopodium polycephalum flow extraction process aiming at the defects in the prior art, has the advantage of improving the content of buddlejasaponins IVb in a clinopodium polycephalum flow extract, is simple in process and can be used for continuous production.
In order to achieve the purpose, the technical scheme of the invention is as follows:
the Chinese medicine clinopodium polycephalum blood stream extraction method comprises the following steps:
s1, weighing the clinopodium polycephalum medicinal material, adding 50-85 vol.% of ethanol as an extraction solvent, heating, refluxing and extracting once, and separating a first ethanol extract and the clinopodium polycephalum medicinal material after extraction is finished;
s2, adding water serving as an extraction solvent into the clinopodium polycephalum medicinal material processed in the step S1, heating, decocting and extracting for one time, and separating a second water extracting solution and clinopodium polycephalum medicinal dregs after extraction is finished;
s3, concentrating the first ethanol extract, adding the second water extract into the concentrated ethanol extract, mixing and concentrating to obtain the clinopodium polycephalum extract.
Preferably, the method further comprises step S4: s4, adjusting the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract by using ethanol until the index requirements of the finished clinopodium polycephalum traditional Chinese medicine extract are met.
Preferably, in the step S1, the mass of the ethanol is 8-10 times of that of the clinopodium polycephalum.
Preferably, in the step S2, the mass of the water is 8-11 times of that of the clinopodium polycephalum herb.
Preferably, in the step S1, the extraction time is 1 to 3 hours.
Preferably, in the step S2, the extraction time is 1 to 3 hours.
Preferably, in the step S3, the first ethanol extract is concentrated by heating and decompressing at a temperature of 45 ℃ to 75 ℃ and a pressure of-0.06 to-0.085 MPa.
Preferably, in the step S3, after the second water extract is added, the mixture is concentrated under normal pressure, wherein the concentration temperature is 80-100 ℃;
or after adding the second water extracting solution, heating and concentrating under reduced pressure at the temperature of 45-75 ℃ and under the pressure of-0.06 to-0.085 Mpa, and then concentrating under normal pressure at the temperature of 80-100 ℃ for not less than 3 hours.
Preferably, the clinopodium polycephalum herb residue is heated to recover ethanol, and the ethanol recovered from the first ethanol extraction solution concentration and the ethanol recovered from the heated clinopodium polycephalum herb residue are used for the next extraction after the concentration is adjusted.
The invention further provides application of the Chinese medicinal clinopodium polycephalum flow extraction method in improving the content of buddlejasaponins IVb in the Chinese medicinal extract of the clinopodium polycephalum flow.
Compared with the prior art, the invention has the advantages that:
1. the extraction method can effectively improve the extraction rate of buddlejasaponins IVb in the clinopodium polycephalum extract, and the content of buddlejasaponins IVb in the clinopodium polycephalum extract can reach 2550 microgram/g according to the mass ratio of the clinopodium polycephalum medicinal material to the clinopodium polycephalum extract of 1: 1.
2. The method has the advantages of simple process flow, low requirement on equipment conditions, suitability for large-scale operation and industrial popularization prospect.
3. The invention adopts low-toxicity ethanol and water as extraction solvents, is green and environment-friendly, hardly has influence on the health of operators, and has no negative influence on the health of users.
Drawings
FIG. 1 is a process flow diagram of the present invention.
Detailed Description
The present invention is further illustrated with reference to the following specific examples and fig. 1, but the scope of the present invention is not limited to the following examples.
Example 1:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 85vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding 11 times of water by mass into the clinopodium polycephalum medicinal material separated by filtration, heating and decocting for 3 hours, filtering, and collecting a second water extract. Heating and concentrating under reduced pressure the first ethanol extractive solution at 60 deg.C under-0.07 Mpa, adding the second water extractive solution, and concentrating at 80 deg.C under normal pressure for 3.5 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the above example 1, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is 1750 mug/g by adopting the high performance liquid chromatography.
Example 2:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 8 times of 70vol.% ethanol-water solution, heating and refluxing for 2 hr, filtering, and collecting the first ethanol extractive solution. Then adding 8 times of water by mass into the clinopodium polycephalum medicinal material separated by filtration, heating and decocting for 2 hours, filtering, and collecting a second water extract. Heating and concentrating under reduced pressure the first ethanol extractive solution at 45 deg.C under-0.085 Mpa, adding the second water extractive solution, and concentrating at 80 deg.C under normal pressure for 3 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the above example 2, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is 1150 mug/g by adopting the high performance liquid chromatography.
Example 3:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 50vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding water with the mass of 10 times into the clinopodium polycephalum medicinal materials separated by filtration, heating and decocting for 3 hours, filtering, and collecting a second water extract. Then heating and concentrating under reduced pressure the first ethanol extractive solution at 75 deg.C under-0.06 Mpa, adding the second water extractive solution, and concentrating at 95 deg.C under normal pressure for 4 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the above example 3, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 2550 mug/g by adopting the high performance liquid chromatography.
Example 4:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 50vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding water with the mass of 10 times into the clinopodium polycephalum medicinal materials separated by filtration, heating and decocting for 3 hours, filtering, and collecting a second water extract. Heating and concentrating under reduced pressure the first ethanol extractive solution at 75 deg.C under-0.06 Mpa, adding the second water extractive solution, concentrating under reduced pressure at 75 deg.C under-0.06 Mpa for 0.5 hr, and concentrating at 95 deg.C under normal pressure for 3 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the above example 3, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 1850 mug/g by high performance liquid chromatography.
Comparative example 1:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 50vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding 10 times of 50vol.% ethanol-water solution into the herba Clinopodii, heating and reflux extracting for 3 hr, filtering, and collecting the second ethanol extract. Then heating and concentrating under reduced pressure the first ethanol extract, adding the second ethanol extract, heating and concentrating under reduced pressure, and concentrating for 4 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the comparative example 1, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 450 mug/g by adopting the high performance liquid chromatography.
Comparative example 2:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of water, heating, refluxing, extracting for 3 hr, filtering, and collecting the first water extractive solution. Then adding 11 times of water by mass into the clinopodium polycephalum medicinal material separated by filtration, extracting for 3 hours, filtering, and collecting a second water extract. Heating, concentrating under reduced pressure, adding the second water extractive solution, and concentrating at 95 deg.C under normal pressure for 3 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the comparative example 2, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 910 mug/g by adopting the high performance liquid chromatography.
Comparative example 3:
removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 95vol.% ethanol-water solution, heating and refluxing for 3 hours, filtering, and collecting the first ethanol extract. Then adding 10 times of water by mass into the clinopodium polycephalum medicinal material separated by filtration, extracting for 3 hours, filtering, and collecting a second water extract. Then heating and concentrating the first ethanol extract under reduced pressure, adding the second water extract, and concentrating at 80 deg.C under normal pressure for 3 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the comparative example 3, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 760 microgram/g by adopting a high performance liquid chromatography.
Comparative example 4
Removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 50vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding water with the mass of 10 times into the clinopodium polycephalum medicinal materials separated by filtration, heating, decocting and extracting for 3 hours, filtering, and collecting a second water extracting solution. Heating and concentrating under reduced pressure the first ethanol extractive solution at 75 deg.C under-0.06 Mpa, adding the second water extractive solution, and concentrating under reduced pressure at 75 deg.C under-0.06 Mpa for 2.5 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the comparative example 3, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is 614 mug/g through high performance liquid chromatography.
Comparative example 5
Removing silt from herba Clinopodii, sun drying, cutting into pieces, and extracting in extraction equipment. Adding 10 times of 50vol.% ethanol-water solution, heating and refluxing for 3 hr, filtering, and collecting the first ethanol extractive solution. Then adding water with the mass of 10 times into the clinopodium polycephalum medicinal materials separated by filtration, heating, decocting and extracting for 3 hours, filtering, and collecting a second water extracting solution. Heating and concentrating under reduced pressure the first ethanol extractive solution at 75 deg.C under-0.06 Mpa, adding the second water extractive solution, concentrating under reduced pressure at 75 deg.C under-0.06 Mpa for 0.8 hr, and concentrating at 95 deg.C under normal pressure for 2.5 hr. Finally, the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract are adjusted by ethanol, and the clinopodium polycephalum extract with the mass ratio of 1:1 is prepared.
In the comparative example 5, the content of the active ingredient buddlejasaponins IVb in the clinopodium polycephalum extract is detected to be 1027 mug/g by adopting the high performance liquid chromatography.
Claims (10)
1. The Chinese medicine clinopodium polycephalum blood stream extraction method is characterized by comprising the following steps:
s1, weighing the clinopodium polycephalum medicinal material, adding 50-85 vol.% of ethanol as an extraction solvent, heating and refluxing for extraction once, and separating a first ethanol extract and the clinopodium polycephalum medicinal material after extraction is finished;
s2, adding water serving as an extraction solvent into the clinopodium polycephalum medicinal material processed in the step S1, heating, decocting and extracting for one time, and separating a second water extracting solution and clinopodium polycephalum medicinal dregs after extraction is finished;
s3, concentrating the first ethanol extract, adding the second water extract into the concentrated ethanol extract, mixing and concentrating to obtain the clinopodium polycephalum extract.
2. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
further comprising step S4: s4, adjusting the weight and the ethanol content of the clinopodium polycephalum traditional Chinese medicine extract by using ethanol until the index requirements of the finished clinopodium polycephalum traditional Chinese medicine extract are met.
3. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S1, the mass of the ethanol is 8-10 times of that of the clinopodium polycephalum medicinal material.
4. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S2, the mass of water is 8-11 times of that of the clinopodium polycephalum medicinal material.
5. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S1, the extraction time is 1-3 h.
6. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S2, the extraction time is 1-3 h.
7. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S3, the first ethanol extract is concentrated by heating and decompressing at the temperature of 45-75 ℃ and under the pressure of-0.06-0.085 MPa.
8. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
in the step S3, after the second water extracting solution is added, concentrating at normal pressure, wherein the concentration temperature is 80-100 ℃;
or after adding the second water extracting solution, heating and concentrating under reduced pressure at the temperature of 45-75 ℃ and under the pressure of-0.06 to-0.085 Mpa, and then concentrating under normal pressure at the temperature of 80-100 ℃ for not less than 3 hours.
9. The method for extracting clinopodium polycephalum of claim 1, which comprises the following steps:
heating herba Clinopodii residue to recover ethanol, concentrating the first ethanol extractive solution to recover ethanol, and adjusting the concentration of ethanol and ethanol recovered from the heated herba Clinopodii residue to obtain ethanol extract for next extraction.
10. The application of the Chinese medicinal clinopodium polycephalum flow extraction method of claims 1-9 in improving the content of buddlejaside IVb in the Chinese medicinal extract of clinopodium polycephalum flow.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011599342.1A CN112641824B (en) | 2020-12-30 | 2020-12-30 | Chinese medicine clinopodium polycephalum flow extraction method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011599342.1A CN112641824B (en) | 2020-12-30 | 2020-12-30 | Chinese medicine clinopodium polycephalum flow extraction method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112641824A true CN112641824A (en) | 2021-04-13 |
CN112641824B CN112641824B (en) | 2022-06-10 |
Family
ID=75364013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011599342.1A Active CN112641824B (en) | 2020-12-30 | 2020-12-30 | Chinese medicine clinopodium polycephalum flow extraction method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112641824B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101804092A (en) * | 2010-04-27 | 2010-08-18 | 南京泽朗医药科技有限公司 | Method for preparing Chinse clinopodium herb total saponins |
-
2020
- 2020-12-30 CN CN202011599342.1A patent/CN112641824B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101804092A (en) * | 2010-04-27 | 2010-08-18 | 南京泽朗医药科技有限公司 | Method for preparing Chinse clinopodium herb total saponins |
Non-Patent Citations (2)
Title |
---|
刘文佳等: "提高断血流提取物指标成分得率的工艺研究", 《口腔护理用品工业》 * |
刘芳等: "断血流提取工艺的研究", 《长治医学院学报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112641824B (en) | 2022-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020073976A1 (en) | Industrial preparation method of lutein and marigold flavone | |
CN104784254A (en) | Extraction method for producing baicalin with biological enzyme method | |
CN104435746A (en) | Method for simultaneously extracting polysaccharides, flavones and alkaloid from dendrobium stem | |
CN102617693B (en) | Method utilizing subcritical water extraction technology to extract and prepare ursolic acid from loquat leaves | |
CN101829210A (en) | Method for preparing apple polyphenol | |
CN107098942B (en) | Method for subcritical water extraction of kaempferitrin in radish leaves | |
CN112641824B (en) | Chinese medicine clinopodium polycephalum flow extraction method | |
CN102784193A (en) | Method for preparing hedysarum polybotrys extract by adopting coupling technology | |
CN109111495B (en) | Method for reducing content of related substances in mono-ammonium glycyrrhizinate | |
CN111548380A (en) | Preparation method of monotropein in morinda officinalis | |
CN102250174A (en) | Method for extracting jasminin from winter jasmine leaves | |
CN102911150B (en) | Process for preparing oligomeric proantho cyanidins by peanut skin | |
CN101723927B (en) | Method for batch production, separation and purification of catechin monomers EGCG | |
CN103739648A (en) | Preparation method for mussaendoside U | |
CN110204588B (en) | Method for preparing astragaloside | |
CN102824473A (en) | Lycium ruthenicum murr total flavonoid extract and preparation method thereof | |
CN107739306B (en) | A method for preparing refined herba Rosmarini officinalis extract | |
CN103739649A (en) | Preparation method for mussaendoside G | |
CN103623753B (en) | The preparation method of the wild golden Lao Mei total-triterpene extract in Daxing'an Mountainrange | |
CN105420293A (en) | Method for separating and purifying resveratrol from traditional Chinese medicine polygonum cuspidatum extraction solution | |
CN102675142B (en) | Method for purifying capsicine in hot pepper | |
CN112043738A (en) | Preparation method of radix angelicae pubescentis active ingredient extract | |
CN106916859B (en) | Method for rapidly extracting liquiritigenin from liquorice waste residue | |
CN102114063B (en) | Method for extracting and separating asiaticoside by combining countercurrent extraction with membrane separation | |
CN110845553A (en) | Method for extracting gastrodin by ultrasonic water bath heating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |